Similarly, Shen et al. reported downregulated expression of miR-22 in de novo AML, finding a reverse association between expression of miR-22 and MECOM(EVI1), and a positive correlation with the expression level of transcription factor PU.1. Here, MECOM is linked to acute myeloid leukemia.